Safeguard Scientifics (NYSE:SFE) coverage initiated by StockNews.com analysts

0

StockNews.com began covering stocks of Safeguard Scientifics (NYSE: SFE – Get a review) in a research note released Sunday to investors. The brokerage has set a “holding” rating on the asset manager’s stock.

Safeguard Scientifics stock opened at $4.28 on Friday. The company has a 50-day moving average price of $4.46 and a two-hundred-day moving average price of $5.88. The company has a market capitalization of $71.16 million, a price-earnings ratio of -85.60 and a beta of 1.05. Safeguard Scientifics has a 52-week minimum of $3.32 and a 52-week maximum of $8.98.

Safeguard Scientifics (NYSE:SFE – Get Rating) last released its quarterly results on Thursday, May 5. The asset manager reported ($0.40) earnings per share for the quarter.

In other news from Safeguard Scientifics, major shareholder Thomas A. Satterfield, Jr. acquired 15,732 shares of the company in a transaction dated Monday, May 23. The stock was purchased at an average price of $3.45 per share, for a total transaction of $54,275.40. Following the purchase, the insider now owns 450,732 shares of the company, valued at approximately $1,555,025.40. The transaction was disclosed in a legal filing with the SEC, accessible via this link. Additionally, major shareholder Thomas A. Satterfield, Jr. acquired 13,646 shares of the company in a transaction dated Wednesday, May 25. The shares were acquired at an average price of $3.79 per share, with a total value of $51,718.34. Following the purchase, the insider now owns 476,904 shares of the company, valued at approximately $1,807,466.16. Disclosure of this purchase can be found here. 7.10% of the shares are currently held by company insiders.

Several hedge funds and other institutional investors have recently changed their holdings in the company. Madison Avenue Partners LP increased its stake in Safeguard Scientifics by 48.7% during the third quarter. Madison Avenue Partners LP now owns 965,242 shares of the asset manager worth $8,571,000 after purchasing an additional 316,209 shares during the period. Levin Capital Strategies LP acquired a new position in Safeguard Scientifics during the fourth quarter worth $1,306,000. Yakira Capital Management Inc. increased its stake in Safeguard Scientifics by 8.1% during the first quarter. Yakira Capital Management Inc. now owns 1,092,108 shares of the asset manager worth $5,701,000 after purchasing an additional 82,158 shares in the last quarter. Two Sigma Advisers LP increased its stake in Safeguard Scientifics by 151.4% during the third quarter. Two Sigma Advisers LP now owns 118,733 shares of the asset manager worth $1,054,000 after buying an additional 71,500 shares in the last quarter. Finally, Clayton Partners LLC increased its stake in Safeguard Scientifics by 21.3% during the first quarter. Clayton Partners LLC now owns 297,066 shares of the asset manager worth $1,551,000 after purchasing an additional 52,172 shares in the last quarter. 60.59% of the shares are currently held by institutional investors.

About Safeguard Scientifics (Get an evaluation)

Safeguard Scientifics, Inc is no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, spin-offs, growth and start-up financing. He initially invests in an AC series round and opportunistically in a seed round.

Further reading



Get news and reviews for Safeguard Scientifics Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Safeguard Scientifics and related companies with MarketBeat.com’s free daily email newsletter.

Share.

Comments are closed.